These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 7878838)
21. [Immunosuppression in living donor liver transplantation from ABO blood type incompatible donors]. Egawa H; Oike F; Tanaka K Nihon Rinsho Meneki Gakkai Kaishi; 2000 Dec; 23(6):636-9. PubMed ID: 11210760 [No Abstract] [Full Text] [Related]
22. Auxiliary partial orthotopic living donor liver transplantation in a patient with Wilson's disease: a case report. Park YK; Kim BW; Wang HJ; Kim MW Transplant Proc; 2008 Dec; 40(10):3808-9. PubMed ID: 19100498 [TBL] [Abstract][Full Text] [Related]
23. Reduction of immunosuppressive agents after living related donor liver transplantation. Tanaka M; Otobe Y; Hashimoto T; Shimizu Y; Suzuki T; Nakamura Y; Itoh K; Satoh M; Ueda N; Manabe T Transplant Proc; 1996 Aug; 28(4):2402-3. PubMed ID: 8769268 [No Abstract] [Full Text] [Related]
24. Video documented follow-up of liver transplantation in Wilson's disease with predominant neurological manifestation. Suess T; Bokemeyer M; Schomerus G; Donnerstag F; Manns MP; Klempnauer J; Kolbe H; Weissenborn K Mov Disord; 2007 May; 22(7):1036-8. PubMed ID: 17357135 [TBL] [Abstract][Full Text] [Related]
26. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation. Ashizawa T; Matsuno N; Yokoyama T; Kihara Y; Kuzuoka K; Taira S; Konno O; Jyojima Y; Akashi I; Nakamura Y; Hama K; Iwamoto H; Iwahori T; Nagao T; Kasahara M; Tanaka K Transplant Proc; 2006 Dec; 38(10):3629-32. PubMed ID: 17175351 [TBL] [Abstract][Full Text] [Related]
27. Revised King's College score for liver transplantation in adult patients with Wilson's disease. Petrasek J; Jirsa M; Sperl J; Kozak L; Taimr P; Spicak J; Filip K; Trunecka P Liver Transpl; 2007 Jan; 13(1):55-61. PubMed ID: 17154398 [TBL] [Abstract][Full Text] [Related]
28. Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease. Schumacher G; Platz KP; Mueller AR; Neuhaus R; Steinmüller T; Bechstein WO; Becker M; Luck W; Schuelke M; Neuhaus P Clin Transplant; 1997 Jun; 11(3):217-24. PubMed ID: 9193846 [TBL] [Abstract][Full Text] [Related]
29. [An adolescent with hemolytic anemia and coagulation disorders as manifestation of Wilson's disease, treated with liver transplantation]. Brouwer RE; Manten A; van Leeuwen AM; Veenendaal RA; Ringers J; van Hoek B Ned Tijdschr Geneeskd; 2001 Feb; 145(7):316-22. PubMed ID: 11234295 [TBL] [Abstract][Full Text] [Related]
30. Segmental living related donor liver transplantation in childhood. Haberal M; Abbasoğlu O; Büyükpamukçu N; Bilgin N; Telatar H; Besim A Transplant Proc; 1993 Jun; 25(3):2200-2. PubMed ID: 8516870 [No Abstract] [Full Text] [Related]
35. [Early diagnosis is crucial for the prognosis of Wilson's disease]. Olsson R; Lindgren A; Frizell M Lakartidningen; 1991 Jan; 88(4):229-30, 232. PubMed ID: 1994169 [No Abstract] [Full Text] [Related]
36. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives. Prasad R; Kaur G; Walia BN Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519 [TBL] [Abstract][Full Text] [Related]
37. Feasibility of ABO-incompatible living donor liver transplantation in the rituximab era. Ikegami T; Shirabe K; Soejima Y; Taketomi A; Maehara Y Liver Transpl; 2010 Nov; 16(11):1332-3; author reply 1334-5. PubMed ID: 21031550 [No Abstract] [Full Text] [Related]
38. Living donor liver transplantation for fulminant hepatic failure from ABO-incompatible donors. Ikegami T; Soejima Y; Taketomi A; Yoshizumi T; Maehara Y Transpl Int; 2008 Mar; 21(3):284-5. PubMed ID: 17937763 [No Abstract] [Full Text] [Related]